000			02291 a2200673 4500
005			20250517004119.0
264		0	_c20150219
008			201502s 0 0 eng d
022			_a1521-7035
024	7		_a10.1016/j.clim.2014.10.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Yao
245	0	0	_aEffective response and delayed toxicities of refractory advanced diffuse large B-cell lymphoma treated by CD20-directed chimeric antigen receptor-modified T cells. _h[electronic resource]
260			_bClinical immunology (Orlando, Fla.) _cDec 2014
300			_a160-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntigens, CD20 _xgenetics
650	0	4	_aCell Line
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aFemale
650	0	4	_aGene Dosage
650	0	4	_aGene Order
650	0	4	_aHumans
650	0	4	_aImmunotherapy, Adoptive _xadverse effects
650	0	4	_aLymphocyte Count
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPositron-Emission Tomography
650	0	4	_aProtein Binding
650	0	4	_aReceptors, Antigen, T-Cell _xgenetics
650	0	4	_aRecombinant Fusion Proteins _xgenetics
650	0	4	_aT-Cell Antigen Receptor Specificity _ximmunology
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aTreatment Outcome
650	0	4	_aTumor Necrosis Factor Receptor Superfamily, Member 9 _xgenetics
700	1		_aZhang, Wen-ying
700	1		_aHan, Qing-wang
700	1		_aLiu, Yang
700	1		_aDai, Han-ren
700	1		_aGuo, Ye-lei
700	1		_aBo, Jian
700	1		_aFan, Hui
700	1		_aZhang, Yan
700	1		_aZhang, Ya-jing
700	1		_aChen, Mei-xia
700	1		_aFeng, Kai-chao
700	1		_aWang, Quan-shun
700	1		_aFu, Xiao-bing
700	1		_aHan, Wei-dong
773	0		_tClinical immunology (Orlando, Fla.) _gvol. 155 _gno. 2 _gp. 160-75
856	4	0	_uhttps://doi.org/10.1016/j.clim.2014.10.002 _zAvailable from publisher's website
999			_c24399343 _d24399343